BioMerieux BacT/ALERT 3D Wins Role in Platelet Collection System

April 4, 2005

BioMerieux, a company in the field of in vitro diagnostics for medical and industrial applications, announced that its BacT/ALERT 3D Microbial Detection System will play an integral role in a single donor platelet technology system. Gambro BCT recently received clearance by the FDA for apheresis platelets to be collected with its Trima and COBE Spectra Collection Systems for routine storage and patient transfusion up to seven days. Clearance was obtained on the condition that the platelets are tested with the bioMerieux BacT/ALERT Microbial Detection System, and used as described in the Gambro BCT seven-day platelet protocol.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/04-01-2005/0003297668&EDATE=)